Notes
The study was funded by Vifor Pharma Group.
Reference
Aksan A, et al. Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland. Advances in Therapy : 20 Nov 2020. Available from: URL: http://doi.org/10.1007/s12325-020-01553-1
Rights and permissions
About this article
Cite this article
Ferric carboxymaltose preferred option in IBD-associated iron deficiency anaemia. PharmacoEcon Outcomes News 867, 15 (2020). https://doi.org/10.1007/s40274-020-7312-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7312-5